285 related articles for article (PubMed ID: 19077040)
1. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
3. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
4. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 suppression impedes medulloblastoma cell migration.
Grunder E; D'Ambrosio R; Fiaschetti G; Abela L; Arcaro A; Zuzak T; Ohgaki H; Lv SQ; Shalaby T; Grotzer M
Eur J Cancer; 2011 Nov; 47(16):2479-90. PubMed ID: 21775132
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant.
Duplan SM; Théorêt Y; Kenigsberg RL
Clin Cancer Res; 2002 Jan; 8(1):246-57. PubMed ID: 11801566
[TBL] [Abstract][Full Text] [Related]
8. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
9. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
[TBL] [Abstract][Full Text] [Related]
11. Large-cell medulloblastoma with arrestin-like protein expression.
Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
13. Mutations in SUFU predispose to medulloblastoma.
Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization.
Yokota N; Mainprize TG; Taylor MD; Kohata T; Loreto M; Ueda S; Dura W; Grajkowska W; Kuo JS; Rutka JT
Oncogene; 2004 Apr; 23(19):3444-53. PubMed ID: 15064731
[TBL] [Abstract][Full Text] [Related]
16. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
Inda MM; Muñoz J; Coullin P; Fauvet D; Danglot G; Tuñón T; Bernheim A; Castresana JS
Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma stem cells: modeling tumor heterogeneity.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
[TBL] [Abstract][Full Text] [Related]
18. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.
Schofield D; West DC; Anthony DC; Marshal R; Sklar J
Am J Pathol; 1995 Feb; 146(2):472-80. PubMed ID: 7856756
[TBL] [Abstract][Full Text] [Related]
19. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
[TBL] [Abstract][Full Text] [Related]
20. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
Sadighi Z; Vats T; Khatua S
J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]